Bottom line
How much do IXJ and DLHIX overlap?
45% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 41.2% of IXJ's assets and 36.7% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings IXJ and DLHIX have in common
| Holding | % of IXJ | % of DLHIX | Overlap |
|---|---|---|---|
| Eli Lilly And Company | 10.93% | 4.16% | 4.16% |
| Abbvie Inc. | 5.12% | 4.19% | 4.19% |
| Unitedhealth Group Incorporated | 4.40% | 3.88% | 3.88% |
| Merck & Co., Inc. | 4.12% | 3.68% | 3.68% |
| Astrazeneca Plc | 3.76% | 3.27% | 3.27% |
| Roche Holding AG | 3.75% | 3.01% | 3.01% |
| Amgen Inc. | 2.54% | 2.27% | 2.27% |
| Gilead Sciences, Inc. | 2.04% | 3.54% | 2.04% |
| Pfizer Inc. | 1.78% | 3.84% | 1.78% |
| Vertex Pharmaceuticals Incorporated | 1.64% | 1.66% | 1.64% |
| Elevance Health, Inc. | 1.09% | 3.25% | 1.09% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IXJ
- Johnson & Johnson — 7.04%
- Novartis AG — 3.71%
- Thermo Fisher Scientific Incorporated — 2.42%
- Abbott Laboratories — 2.05%
- Novo Nordisk A/s — 1.99%
- Intuitive Surgical, Inc. — 1.83%
- Cvs Health Corporation — 1.71%
- Danaher Corporation — 1.56%
- Bristol-myers Squibb Company — 1.53%
- Stryker Corporation — 1.41%
- Gsk Plc — 1.38%
- Medtronic Public Limited Company — 1.30%
- Sanofi Sa — 1.18%
- Mckesson Corporation — 1.18%
Only in DLHIX
- Ucb Sa — 5.19%
- Regeneron Pharmaceuticals Inc — 3.91%
- Chugai Pharmaceutical Co Ltd — 2.77%
- Viatris Inc — 2.48%
- Oruka Therapeutics Inc — 2.41%
- Halozyme Therapeutics Inc — 2.30%
- Illumina Inc — 2.11%
- Alkermes Plc — 1.82%
- Viking Therapeutics Inc — 1.72%
- Roivant Sciences Ltd — 1.60%
- Neurocrine Biosciences Inc — 1.57%
- Arcus Biosciences Inc — 1.56%
- Zimmer Biomet Holdings Inc — 1.42%
- Boston Scientific Corp — 1.42%
Asset mix
| Asset type | IXJ | DLHIX |
|---|---|---|
| Stocks | 99.6% | 94.8% |
| Preferred stock | — | 3.0% |
| Cash & short-term funds | 1.3% | 2.0% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | IXJ | DLHIX |
|---|---|---|
| US | 70.6% | 75.4% |
| CH | 10.4% | 3.0% |
| GB | 5.8% | 3.3% |
| BE | 0.5% | 5.2% |
| JP | 3.7% | 2.8% |
| IE | 1.6% | 3.2% |
| DK | 2.3% | — |
| FR | 2.0% | 2.0% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do IXJ and DLHIX overlap?
What stocks do IXJ and DLHIX have in common?
Should I own both IXJ and DLHIX?
Which holds more stocks, IXJ or DLHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.